137 related articles for article (PubMed ID: 9124807)
1. Midbrain dopaminergic neuronal degeneration in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Kostic V; Gurney ME; Deng HX; Siddique T; Epstein CJ; Przedborski S
Ann Neurol; 1997 Apr; 41(4):497-504. PubMed ID: 9124807
[TBL] [Abstract][Full Text] [Related]
2. Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Chiu AY; Zhai P; Dal Canto MC; Peters TM; Kwon YW; Prattis SM; Gurney ME
Mol Cell Neurosci; 1995 Aug; 6(4):349-62. PubMed ID: 8846004
[TBL] [Abstract][Full Text] [Related]
3. Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of amyotrophic lateral sclerosis.
Andreassen OA; Ferrante RJ; Klivenyi P; Klein AM; Shinobu LA; Epstein CJ; Beal MF
Ann Neurol; 2000 Apr; 47(4):447-55. PubMed ID: 10762155
[TBL] [Abstract][Full Text] [Related]
4. Loss of prion protein in a transgenic model of amyotrophic lateral sclerosis.
Dupuis L; Mbebi C; Gonzalez de Aguilar JL; Rene F; Muller A; de Tapia M; Loeffler JP
Mol Cell Neurosci; 2002 Feb; 19(2):216-24. PubMed ID: 11860274
[TBL] [Abstract][Full Text] [Related]
5. Enhanced oxygen radical production in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Liu R; Althaus JS; Ellerbrock BR; Becker DA; Gurney ME
Ann Neurol; 1998 Nov; 44(5):763-70. PubMed ID: 9818932
[TBL] [Abstract][Full Text] [Related]
6. Identification of three mutations in the Cu,Zn-superoxide dismutase (Cu,Zn-SOD) gene with familial amyotrophic lateral sclerosis: transduction of human Cu,Zn-SOD into PC12 cells by HIV-1 TAT protein basic domain.
Chou CM; Huang CJ; Shih CM; Chen YP; Liu TP; Chen CT
Ann N Y Acad Sci; 2005 May; 1042():303-13. PubMed ID: 15965076
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic mechanisms in familial amyotrophic lateral sclerosis due to mutation of Cu, Zn superoxide dismutase.
Gurney ME; Cutting FB; Zhai P; Andrus PK; Hall ED
Pathol Biol (Paris); 1996 Jan; 44(1):51-6. PubMed ID: 8734301
[TBL] [Abstract][Full Text] [Related]
8. Effects of wild-type and mutated copper/zinc superoxide dismutase on neuronal survival and L-DOPA-induced toxicity in postnatal midbrain culture.
Mena MA; Khan U; Togasaki DM; Sulzer D; Epstein CJ; Przedborski S
J Neurochem; 1997 Jul; 69(1):21-33. PubMed ID: 9202290
[TBL] [Abstract][Full Text] [Related]
9. Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis.
Cutler RG; Pedersen WA; Camandola S; Rothstein JD; Mattson MP
Ann Neurol; 2002 Oct; 52(4):448-57. PubMed ID: 12325074
[TBL] [Abstract][Full Text] [Related]
10. Comparison of pathological alterations in ALS and a murine transgenic model: pathogenetic implications.
Dal Canto MC
Clin Neurosci; 1995-1996; 3(6):332-7. PubMed ID: 9021254
[TBL] [Abstract][Full Text] [Related]
11. Light-induced retinal damage in mice carrying a mutated SOD I gene.
Mittag TW; Bayer AU; La VAIL MM
Exp Eye Res; 1999 Dec; 69(6):677-83. PubMed ID: 10620397
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic benefits of putrescine-modified catalase in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Reinholz MM; Merkle CM; Poduslo JF
Exp Neurol; 1999 Sep; 159(1):204-16. PubMed ID: 10486188
[TBL] [Abstract][Full Text] [Related]
13. ALS-linked Cu/Zn-SOD mutation impairs cerebral synaptic glucose and glutamate transport and exacerbates ischemic brain injury.
Guo Z; Kindy MS; Kruman I; Mattson MP
J Cereb Blood Flow Metab; 2000 Mar; 20(3):463-8. PubMed ID: 10724110
[TBL] [Abstract][Full Text] [Related]
14. Amyotrophic lateral sclerosis and Alzheimer disease. Lessons from model systems.
Price DL; Wong PC; Borchelt DR; Pardo CA; Thinakaran G; Doan AP; Lee MK; Martin LJ; Sisodia SS
Rev Neurol (Paris); 1997 Sep; 153(8-9):484-95. PubMed ID: 9683997
[TBL] [Abstract][Full Text] [Related]
15. ALS-linked Cu/Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis.
Kruman II; Pedersen WA; Springer JE; Mattson MP
Exp Neurol; 1999 Nov; 160(1):28-39. PubMed ID: 10630188
[TBL] [Abstract][Full Text] [Related]
16. Proteasome inhibition enhances the stability of mouse Cu/Zn superoxide dismutase with mutations linked to familial amyotrophic lateral sclerosis.
Hoffman EK; Wilcox HM; Scott RW; Siman R
J Neurol Sci; 1996 Jul; 139(1):15-20. PubMed ID: 8836967
[TBL] [Abstract][Full Text] [Related]
17. Glycation proceeds faster in mutated Cu, Zn-superoxide dismutases related to familial amyotrophic lateral sclerosis.
Takamiya R; Takahashi M; Myint T; Park YS; Miyazawa N; Endo T; Fujiwara N; Sakiyama H; Misonou Y; Miyamoto Y; Fujii J; Taniguchi N
FASEB J; 2003 May; 17(8):938-40. PubMed ID: 12626432
[TBL] [Abstract][Full Text] [Related]
18. Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Andrus PK; Fleck TJ; Gurney ME; Hall ED
J Neurochem; 1998 Nov; 71(5):2041-8. PubMed ID: 9798929
[TBL] [Abstract][Full Text] [Related]
19. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions.
Tu PH; Raju P; Robinson KA; Gurney ME; Trojanowski JQ; Lee VM
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3155-60. PubMed ID: 8610185
[TBL] [Abstract][Full Text] [Related]
20. Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS).
Dal Canto MC; Gurney ME
Brain Res; 1995 Apr; 676(1):25-40. PubMed ID: 7796176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]